MCID: SCC001
MIFTS: 52

Succinic Semialdehyde Dehydrogenase Deficiency malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases

Aliases & Classifications for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Aliases & Descriptions for Succinic Semialdehyde Dehydrogenase Deficiency:

Name: Succinic Semialdehyde Dehydrogenase Deficiency 49 10 11 21 45 22 23 12 51 67 65
4-Hydroxybutyric Aciduria 10 21 45 22 23 51 67
Gamma-Hydroxybutyric Aciduria 10 21 22 23 51 67
Ssadh Deficiency 21 45 22 23 51 67
Succinate Semialdehyde Dehydrogenase Deficiency 67 24
Gaba Metabolic Defect 45 67
 
Succinic Semialdehyde Dehydrogenase 11
Gamma-Hydroxybutyric Acidemia 23
Gamma-Hydroxybutyricaciduria 45
4-Hydroxybutyricaciduria 23
Ssadhd 67
Ssadh 10

Characteristics:

Orphanet epidemiological data:

51
succinic semialdehyde dehydrogenase deficiency:
Inheritance: Autosomal recessive; Age of onset: Childhood

HPO:

61
succinic semialdehyde dehydrogenase deficiency:
Onset and clinical course: phenotypic variability, infantile onset
Inheritance: autosomal recessive inheritance


Classifications:



External Ids:

OMIM49 271980
Disease Ontology10 DOID:0060175
Orphanet51 22
ICD10 via Orphanet28 E72.8
MedGen34 C0268631
MeSH36 D000592
UMLS65 C0268631

Summaries for Succinic Semialdehyde Dehydrogenase Deficiency

About this section
Genetics Home Reference:23 Succinic semialdehyde dehydrogenase deficiency is a disorder that can cause a variety of neurological problems. People with this condition typically have developmental delay, especially involving speech development; intellectual disability; and decreased muscle tone (hypotonia) soon after birth. About half of those affected experience seizures, difficulty coordinating movements (ataxia), decreased reflexes (hyporeflexia), and behavioral problems. The most common behavioral problems associated with this condition are sleep disturbances, hyperactivity, difficulty maintaining attention, and anxiety. Less frequently, affected individuals may have increased aggression, hallucinations, obsessive-compulsive disorder (OCD), and self-injurious behavior, including biting and head banging. People with this condition can also have problems controlling eye movements. Less common features of succinic semialdehyde dehydrogenase deficiency include uncontrollable movements of the limbs (choreoathetosis), involuntary tensing of the muscles (dystonia), muscle twitches (myoclonus), and a progressive worsening of ataxia.

MalaCards based summary: Succinic Semialdehyde Dehydrogenase Deficiency, also known as 4-hydroxybutyric aciduria, is related to pericarditis and schizophrenia, and has symptoms including cognitive impairment, incoordination and muscular hypotonia. An important gene associated with Succinic Semialdehyde Dehydrogenase Deficiency is ALDH5A1 (Aldehyde Dehydrogenase 5 Family Member A1), and among its related pathways are Valproic Acid Pathway, Pharmacodynamics and Propanoate metabolism. Affiliated tissues include eye, brain and heart.

Disease Ontology:10 A gamma-amino butyric acid metabolism disorder that is characterized by a deficiency of succinic semialdehyde dehydrogenase resulting in elevated levels of gamma-hydroxybutyric acid.

NIH Rare Diseases:45 Succinic semialdehyde dehydrogenase (ssadh) deficiency is disorder that can cause a variety of neurological and neuromuscular problems. the signs and symptoms can be extremely variable among affected individuals and may include mild to severe intellectual disability; developmental delay (especially involving speech); hypotonia; difficulty coordinating movements (ataxia); and/or seizures. some affected individuals may also have decreased reflexes (hyporeflexia); nystagmus; hyperactivity; and/or behavioral problems. ssadh deficiency is caused by mutations in the aldh5a1 gene and is inherited in an autosomal recessive manner. management is generally symptomatic and typically focuses on treating seizures and neurobehavioral issues. last updated: 9/25/2013

UniProtKB/Swiss-Prot:67 Succinic semialdehyde dehydrogenase deficiency: A rare inborn error of 4-aminobutyric acid (GABA) metabolism, which leads to accumulation of 4-hydroxybutyric acid in physiologic fluids of patients. The disease is clinically characterized by developmental delay, hypotonia, mental retardation, ataxia, seizures, hyperkinetic behavior, aggression, and sleep disturbances.

OMIM:49 Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare autosomal recessive neurologic disorder in which an... (271980) more...

Wikipedia:68 Succinic semialdehyde dehydrogenase deficiency (SSADHD), also known as 4-hydroxybutyric aciduria or... more...

GeneReviews summary for NBK1195

Related Diseases for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Graphical network of the top 20 diseases related to Succinic Semialdehyde Dehydrogenase Deficiency:



Diseases related to succinic semialdehyde dehydrogenase deficiency

Symptoms for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Symptoms by clinical synopsis from OMIM:

271980

Clinical features from OMIM:

271980

Symptoms:

 51 (show all 7)
  • ataxia/incoordination/trouble of the equilibrium
  • hypotonia
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • organic acid metabolism anomalies
  • autosomal recessive inheritance
  • seizures/epilepsy/absences/spasms/status epilepticus
  • psychic/behavioural troubles

HPO human phenotypes related to Succinic Semialdehyde Dehydrogenase Deficiency:

(show all 26)
id Description Frequency HPO Source Accession
1 cognitive impairment hallmark (90%) HP:0100543
2 incoordination hallmark (90%) HP:0002311
3 muscular hypotonia hallmark (90%) HP:0001252
4 seizures typical (50%) HP:0001250
5 self-injurious behavior HP:0100716
6 hyperkinesis HP:0002487
7 eeg abnormality HP:0002353
8 status epilepticus HP:0002133
9 generalized myoclonic seizures HP:0002123
10 absence seizures HP:0002121
11 generalized tonic-clonic seizures HP:0002069
12 abnormality of metabolism/homeostasis HP:0001939
13 motor delay HP:0001270
14 hyporeflexia HP:0001265
15 global developmental delay HP:0001263
16 muscular hypotonia HP:0001252
17 ataxia HP:0001251
18 intellectual disability HP:0001249
19 hyperactivity HP:0000752
20 delayed speech and language development HP:0000750
21 anxiety HP:0000739
22 hallucinations HP:0000738
23 aggressive behavior HP:0000718
24 autism HP:0000717
25 psychosis HP:0000709
26 abnormality of eye movement HP:0000496

Drugs & Therapeutics for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Drugs for Succinic Semialdehyde Dehydrogenase Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Protective AgentsPhase 1, Phase 25651
2(3-aminopropyl)(n-butyl)phosphinic acidPhase 1, Phase 22
3Neurotransmitter AgentsPhase 1, Phase 214795
4Neuroprotective AgentsPhase 1, Phase 21376
5
Taurineexperimental, Nutraceutical26107-35-71123
Synonyms:
1-Aminoethane-2-sulfonate
1-Aminoethane-2-sulfonic acid
2-Aminoethanesulfonate
2-Aminoethanesulfonic acid
2-Aminoethylsulfonate
2-Aminoethylsulfonic acid
 
2-Sulfoethylamine
Aminoethylsulfonate
Aminoethylsulfonic acid
Taurine
b-Aminoethylsulfonate
b-Aminoethylsulfonic acid
beta-Aminoethylsulfonate
beta-Aminoethylsulfonic acid

Interventional clinical trials:

idNameStatusNCT IDPhase
1Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase DeficiencyRecruitingNCT02019667Phase 1, Phase 2
2PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase DeficiencyCompletedNCT00246870
3Brain Excitability in Patients With Succinic Semialdehyde Dehydrogenase DeficiencyCompletedNCT00132366
4Taurine Therapy for SSADH DeficiencyCompletedNCT01608178

Search NIH Clinical Center for Succinic Semialdehyde Dehydrogenase Deficiency

Genetic Tests for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Genetic tests related to Succinic Semialdehyde Dehydrogenase Deficiency:

id Genetic test Affiliating Genes
1 Succinic Semialdehyde Dehydrogenase Deficiency22 ALDH5A1

Anatomical Context for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

MalaCards organs/tissues related to Succinic Semialdehyde Dehydrogenase Deficiency:

33
Eye, Brain, Heart, Pancreas, Kidney, Ovary, Myeloid

Animal Models for Succinic Semialdehyde Dehydrogenase Deficiency or affiliated genes

About this section

Publications for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Articles related to Succinic Semialdehyde Dehydrogenase Deficiency:

(show top 50)    (show all 68)
idTitleAuthorsYear
1
Unmasking a Role for Noninvasive Ventilation in Early Acute Respiratory Distress Syndrome. (27179463)
2016
2
Dissociation of Bak I+1 helix from the core and latch domains is required for apoptosis. (25880232)
2015
3
Acute Respiratory Distress Syndrome in Lemierre's Syndrome. (25143837)
2014
4
Continuous Ultrafiltration for Congestive Heart Failure: The CUORE Trial. (24269855)
2014
5
Drug Discovery for Human African Trypanosomiasis: Identification of Novel Scaffolds by the Newly Developed HTS SYBR Green Assay for Trypanosoma brucei. (25342146)
2014
6
Galectin fingerprinting in naso-sinusal diseases. (24859692)
2014
7
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. (23998706)
2013
8
Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. (23945156)
2013
9
Polymorphisms of interferon gamma gene and risk of hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection. (24719951)
2013
10
Hybrid stenting of aortic coarctation in very low birth weight premature infant. (22431483)
2013
11
Management of twin anemia-polycythemia sequence using intrauterine blood transfusion for the donor and partial exchange transfusion for the recipient. (23713060)
2013
12
Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district. (21848413)
2012
13
A retinoblastoma orthologue is a major regulator of S-phase, mitotic, and developmental gene expression in Dictyostelium. (22768168)
2012
14
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. (21205674)
2011
15
Indeterminate cell histiocytosis in association with acute myeloid leukemia. (20672000)
2010
16
Relapsing polychondritis: new therapeutic strategies with biological agents. (19685056)
2010
17
Images in cardiovascular medicine: Pentalogy of Cantrell associated with thoracoabdominal ectopia cordis. (19380628)
2009
18
Molding therapy of positional plagiocephaly: subjective outcome and quality of life. (18216665)
2008
19
Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. (18514931)
2008
20
Ceramide accelerates ultraviolet-induced MMP-1 expression through JAK1/STAT-1 pathway in cultured human dermal fibroblasts. (18664717)
2008
21
Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. (18423813)
2008
22
High expression of TROP2 correlates with poor prognosis in pancreatic cancer. (18813308)
2008
23
Age-related change in the retinoid X receptor beta gene expression in peripheral blood mononuclear cells of healthy volunteers: effect of 13-cis retinoic acid supplementation. (17916375)
2007
24
VIP is a transcriptional target of Nurr1 in dopaminergic cells. (16999955)
2007
25
Evaluation of man-tailored cellulose-based carriers in glucoamylase immobilization. (17359947)
2007
26
Microadenomatosis of the pancreas in von Hippel-Lindau disease. (17122523)
2006
27
The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon. (17135373)
2006
28
Concerted conformational effects of Ca2+ and ATP are required for activation of sequential reactions in the Ca2+ ATPase (SERCA) catalytic cycle. (17105196)
2006
29
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. (16761963)
2006
30
Cutaneous miliary tuberculosis in two patients with HIV infection. (15097943)
2004
31
Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. (15072920)
2004
32
Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. (15146434)
2004
33
NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. (14633990)
2003
34
Exploration of the active site of dipeptidyl peptidase IV from Porphyromonas gingivalis. Comparison with the human enzyme. (12675220)
2003
35
Meningococcal meningitis epidemic. A new role for single-dose oily chloramphenicol. (23978966)
2002
36
Characterization of alpha(2-->6)-sialyltransferase reaction intermediates: use of alternative substrates to unmask kinetic isotope effects. (12418223)
2002
37
A novel quality control compartment derived from the endoplasmic reticulum. (11408579)
2001
38
Necrobiosis lipoidica. Indolent plaques may signal diabetes. (11265368)
2001
39
3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone. (11168980)
2001
40
Energetically most likely substrate and active-site protonation sites and pathways in the catalytic mechanism of dihydrofolate reductase. (11472112)
2001
41
Retroperitoneal liposarcoma presenting a indirect inguinal hernia. (11246977)
2001
42
Vaccination against type 1 diabetes at the clinical trial stage]. (10194908)
1999
43
Rhabdomyolysis and renal function impairment after isolated limb perfusion--comparison between the effects of perfusion with rhTNF alpha and a 'triple-drug' regimen. (9274441)
1997
44
Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. (9215671)
1997
45
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. (8544269)
1996
46
Detection of primary hyperoxaluria type 2 (L-glyceric aciduria) in patients with maintained renal function or end-stage renal failure. (8538930)
1995
47
The kinase inhibitor staurosporine induces G1 arrest at two points: effect on retinoblastoma protein phosphorylation and cyclin-dependent kinase 2 in normal and transformed cells. (7954429)
1994
48
An adrenaline-secreting ganglioneuroblastoma with elevated urinary HMMA but normal metanephrine excretion. (1489167)
1992
49
Comparison of two automated nephelometers. (1432366)
1992
50
Benign intracranial hypertension without papilledema: case report. (503301)
1979

Variations for Succinic Semialdehyde Dehydrogenase Deficiency

About this section

UniProtKB/Swiss-Prot genetic disease variations for Succinic Semialdehyde Dehydrogenase Deficiency:

67 (show all 12)
id Symbol AA change Variation ID SNP ID
1ALDH5A1p.Cys93PheVAR_026199
2ALDH5A1p.Gly176ArgVAR_026200
3ALDH5A1p.Cys223TyrVAR_026201
4ALDH5A1p.Thr233MetVAR_026202
5ALDH5A1p.Asn255SerVAR_026203
6ALDH5A1p.Gly268GluVAR_026204
7ALDH5A1p.Asn335LysVAR_026205
8ALDH5A1p.Pro382LeuVAR_026206
9ALDH5A1p.Pro382GlnVAR_026207
10ALDH5A1p.Gly409AspVAR_026208
11ALDH5A1p.Val487GluVAR_026209
12ALDH5A1p.Gly533ArgVAR_026210

Clinvar genetic disease variations for Succinic Semialdehyde Dehydrogenase Deficiency:

5
id Gene Variation Type Significance SNP ID Assembly Location
1ALDH5A1ALDH5A1, IVS9, G-T, +1single nucleotide variantPathogenic
2ALDH5A1ALDH5A1, IVS5, G-A, +1single nucleotide variantPathogenic
3ALDH5A1NM_170740.1(ALDH5A1): c.612G> A (p.Trp204Ter)single nucleotide variantPathogenicrs118203982GRCh37Chr 6, 24505099: 24505099
4ALDH5A1NM_170740.1(ALDH5A1): c.1273C> T (p.Arg425Ter)single nucleotide variantPathogenicrs118203983GRCh37Chr 6, 24528285: 24528285
5ALDH5A1NM_001080.3(ALDH5A1): c.1226G> A (p.Gly409Asp)single nucleotide variantPathogenicrs118203984GRCh37Chr 6, 24528277: 24528277
6ALDH5A1NG_008161.1: g.31299_33753del2455deletionPathogenicGRCh37Chr 6, 24521495: 24523949

Expression for genes affiliated with Succinic Semialdehyde Dehydrogenase Deficiency

About this section
Search GEO for disease gene expression data for Succinic Semialdehyde Dehydrogenase Deficiency.

Pathways for genes affiliated with Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Pathways related to Succinic Semialdehyde Dehydrogenase Deficiency according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.8ABAT, ALDH5A1
29.6ABAT, ALDH6A1
3
Show member pathways
9.3GAD1, GAD2
49.3GAD1, GAD2
59.3GAD1, GAD2
69.3GAD1, GAD2
7
Show member pathways
9.2ALDH1B1, ALDH3A2
89.2ALDH1B1, ALDH3A2
9
Show member pathways
9.2ALDH1B1, ALDH3A2
10
Show member pathways
9.0ABAT, GAD1, GAD2
11
Show member pathways
9.0ABAT, GAD1, GAD2
12
Show member pathways
8.8ALDH1B1, ALDH3A2, ALDH4A1
13
Show member pathways
8.7ABAT, ALDH5A1, GAD1, GAD2
14
Show member pathways
8.7ABAT, ALDH5A1, GAD1, GAD2
15
Show member pathways
8.7ABAT, ALDH5A1, GAD1, GAD2
16
Show member pathways
8.3ABAT, ALDH1B1, ALDH3A2, ALDH6A1
178.3ABAT, ALDH4A1, ALDH5A1, GAD1, GAD2
18
Show member pathways
7.2ABAT, ALDH4A1, ALDH5A1, GAD1, GAD2
19
Show member pathways
6.1ABAT, AKR7A2, ALDH1B1, ALDH3A2, ALDH4A1, ALDH5A1

GO Terms for genes affiliated with Succinic Semialdehyde Dehydrogenase Deficiency

About this section

Cellular components related to Succinic Semialdehyde Dehydrogenase Deficiency according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1clathrin-sculpted gamma-aminobutyric acid transport vesicle membraneGO:00612029.3GAD1, GAD2

Biological processes related to Succinic Semialdehyde Dehydrogenase Deficiency according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1gamma-aminobutyric acid metabolic processGO:000944810.4ABAT, ALDH5A1
2neurotransmitter catabolic processGO:004213510.3ABAT, ALDH5A1
3neurotransmitter secretionGO:00072699.5ABAT, ALDH5A1, GAD1
4metabolic processGO:00081528.3ABAT, ALDH1B1, ALDH3A2, ALDH6A1

Sources for Succinic Semialdehyde Dehydrogenase Deficiency

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet